Boehringer Ingelheim Vetmedica Inc. (BIVI) announced Nov. 15 that, as part of its integration planning with Sanofi’s animal health business (Merial), the company will locate its North American and U.S. Animal Health headquarters in Duluth, Ga., upon the closing of the Boehringer Ingelheim asset swap transaction with Sanofi that was signed in June 2016.
Following closing, the company’s U.S. Animal Health leadership team will be based at the existing Merial facility in Duluth, while
All access premium subscription
This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.
Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)
Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.
SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx
TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx